
674PDPerioperative FLOT + anti-PD-L1 avelumab (FLOT-A) chemo-immunotherapy in resectable oesophagogastric adenocarcinoma (OGA): Safety and biomarker data from the ICONIC trial safety run-in
Davidson, M, Mansukhani, S, Starling, N, Chau, I, Watkins, D, Cunningham, D, Rao, S, Lazaro-Alcausi, R, Griffiths, B, Barber, L, Morganstein, D, Forster, M D, Davies, S, Begum, R, Gillbanks, A, KalaitVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.002
Date:
October, 2019
Fichier:
PDF, 78 KB
2019